Results 11 to 20 of about 25,524 (191)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

Virology Journal, 2010
Background Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resistant A(H1N1) viruses have circulated worldwide since the 2007-2008 influenza season.
Itagaki Tsutomu, Takashita Emi, Sugawara Kanetsu, Sanjoh Kanako, Abiko Chieko, Suto Asuka, Aoki Yoko, Mizuta Katsumi, Matsuzaki Yoko, Katsushima Yuriko, Ujike Makoto, Obuchi Masatsugu, Odagiri Takato, Tashiro Masato   +13 more
doaj   +2 more sources

Oseltamivir Enhances Hippocampal Network Synchronization

Journal of Pharmacological Sciences, 2008
Oseltamivir, a widely used anti-influenza drug, inhibits virus neuraminidase. A mammalian homologue of this enzyme is expressed in the brain, yet the effect of oseltamivir on central neurons is largely unknown.
Atsushi Usami, Takuya Sasaki, Nobuhiro Satoh, Takahiro Akiba, Satoshi Yokoshima, Tohru Fukuyama, Kenzo Yamatsugu, Motomu Kanai, Masakatsu Shibasaki, Norio Matsuki, Yuji Ikegaya   +10 more
doaj   +2 more sources

Acute Cheilitis Associated with Oseltamivir after Influenzae A Infection

Case Reports in Pediatrics, 2023
Oseltamivir is a neuraminidase inhibitor used to treat acute influenza A or B in adult and pediatric patients. Adverse reactions are usually mild. Here, we report novel side effects associated with oseltamivir.
Koji Yokoyama, Mitsukazu Mamada
doaj   +2 more sources

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers

Drug Design, Development and Therapy, 2017
Kyungho Jang,1,2,* Min-Kyoung Kim,3,4,* Jaeseong Oh,1 SeungHwan Lee,1 Joo-Youn Cho,1 Kyung-Sang Yu,1 Tai Kiu Choi,3 Sang-Hyuk Lee,3,4 Kyoung Soo Lim4 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine ...
Jang K, Kim M, Oh J, Lee S, Cho JY, Yu KS, Choi TK, Lee SH, Lim KS   +8 more
doaj   +1 more source

Oseltamivir

Journal of Postgraduate Medicine, 2009
Oseltamivir, a selective neuraminidase enzyme inhibitor, has gained worldwide attention in view of Influenza A (H1N1) pandemic. It is one of the most important drugs effective against the novel influenza virus. Oseltamivir is used for the treatment of uncomplicated acute illness due to influenza infection.
Tullu, M. S.
openaire   +3 more sources

The anti-influenza drug oseltamivir evokes hypothermia in mice through dopamine D2 receptor activation via central actions

Journal of Pharmacological Sciences, 2018
Oseltamivir has a hypothermic effect in mice when injected intraperitoneally (i.p.) and intracerebroventricularly (i.c.v.). Here we show that the hypothermia evoked by i.c.v.-oseltamivir is inhibited by non-selective dopamine receptor antagonists ...
Akihiro Fukushima, Arisa Fukui, Yuki Takemura, Yasuhiro Maeda, Hideki Ono   +4 more
doaj   +2 more sources

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States

Emerging Infectious Diseases, 2011
During April 2009–June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant.
Samuel B. Graitcer, Larisa Gubareva, Laurie Kamimoto, Saumil Doshi, Meredith Vandermeer, Janice Louie, Christine Waters, Zack Moore, Katrina Sleeman, Margaret Okomo-Adhiambo, Steven A. Marshall, Kirsten St. George, Chao-Yang Pan, Jennifer M. LaPlante, Alexander Klimov, Alicia M. Fry   +15 more
doaj   +2 more sources

Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis. [PDF]

PLoS ONE, 2016
BACKGROUND:Influenza is a common viral respiratory infection that causes epidemics and pandemics in the human population. Oseltamivir is a neuraminidase inhibitor-a new class of antiviral therapy for influenza.
Kunling Shen, Tengbin Xiong, Seng Chuen Tan, Jiuhong Wu   +3 more
doaj   +1 more source

Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis

Frontiers in Pharmacology, 2022
Background: As a cause of respiratory tract infections in humans, influenza remains with high morbidity and mortality, with associated significant healthcare burden and increased financial burden.
Yingying Peng, Yingying Peng, Zhe Chen, Huanmin Li, Huanmin Li, Yaowei Han, Yaowei Han, Dan Sun, Dan Sun, Yanjiao Li, Yanjiao Li, Xiaoxia Wu, Xiaoxia Wu, Hongxiang Chen, Hongxiang Chen, Xinmin Li, Xinmin Li   +16 more
doaj   +1 more source

A Cross-Sectional Study of Psychiatric Manifestations Following Oseltamivir Administration for Suspected Patients with H1N1 Swine Influenza Infection [PDF]

Journal of Cardio-Thoracic Medicine, 2022
Introduction: Oseltamivir is an antiviral drug used to treat H1N1 influenza. FDA added a warning to the label of oseltamivir drawing attention to the risk of developing neuropsychiatric adverse events.
Basavaraju Jayadeva, Shankar Kumar, Sushmitha Kota, Aashik Shekar   +3 more
doaj   +1 more source